Business · 05/08/2016Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting on Cellular, Tissue, and Gene Therapies
Summary
The FDA is hosting a public meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee to provide advice on FDA's regulatory issues, with at least one portion closed to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →